Overview

EMLA Cream as Analgesic for Outpatient Gynecological Procedures

Status:
Enrolling by invitation
Trial end date:
2024-02-28
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare pain perception in the study participant population undergoing the following gynecological procedures: Intra Uterine Device (IUD) insertion, hysteroscopy, and endometrial biopsy and given either Eutectic Mixture of Local Anesthetics (EMLA) cream or a placebo. The main question to answer is: • Does EMLA cream reduce pain when administered during the following gynecological procedures: IUD insertion, hysteroscopy, and endometrial biopsy? Participants will be asked to do assess their pain on the Visual Analogue Scale through 3 times during the procedure. Researchers will compare the study group with those receiving placebo group to see if there is a difference in pain scores.
Phase:
Phase 4
Details
Lead Sponsor:
CAMC Health System
Treatments:
Lidocaine, Prilocaine Drug Combination